The DOI matches its Crossref record; 48 of the 48 references it cites were found in a registry or an index.
A Role for iNOS in Fasting Hyperglycemia and Impaired Insulin Signaling in the Liver of Obese Diabetic Mice
Open accessAbstract
Chronic inflammation has been postulated to play an important role in the pathogenesis of insulin resistance. Inducible nitric oxide synthase (iNOS) has been implicated in many human diseases associated with inflammation. iNOS deficiency was shown to prevent high-fat diet-induced insulin resistance in skeletal muscle but not in the liver. A role for iNOS in fasting hyperglycemia and hepatic insulin resistance, however, remains to be investigated in obesity-related diabetes. To address this issue, we examined the effects of a specific inhibitor for iNOS, L-NIL, in obese diabetic (ob/ob) mice. iNOS expression was increased in the liver of ob/ob mice compared with wild-type mice. Treatment with iNOS inhibitor reversed fasting hyperglycemia with concomitant amelioration of hyperinsulinemia and improved insulin sensitivity in ob/ob mice. iNOS inhibitor also increased the protein expression of insulin receptor substrate (IRS)-1 and -2 1.5- and 2-fold, respectively, and enhanced IRS-1- and IRS-2-mediated insulin signaling in the liver of ob/ob mice. Exposure to NO donor and ectopically expressed iNOS decreased the protein expression of IRS-1 and -2 in cultured hepatocytes. These results suggest that iNOS plays a role in fasting hyperglycemia and contributes to hepatic insulin resistance in ob/ob mice.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“and the use of an NOS2-specific inhibitor (L-NIL) reversed hyperglycemia, hyperinsulinemia, and insulin resistance in ob/ob mice [150].”
From Regulation of obesity and insulin resistance by nitric oxide (2014) · cites this paper as [150]
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Role of transcription factor NF-kappa B/Rel in induction of nitric oxide synthase.
Xie, Q. W., Kashiwabara, Y., & Nathan, C. (1994) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(17)37600-7 · Cited by 2,212 · cited 2×
“Inducible nitric oxide synthase (iNOS; also termed NOS2), whose expression is regulated by IKK –NF- B (6), is assumed to be one of the candidates that mediate inflammation-involved insulin resistance.”
Yuan, M., Konstantopoulos, N., Lee, J., Hansen, L., Li, Z.-W., Karin, M., & Shoelson, S. E. (2001) · Science · doi:10.1126/science.1061620 · Cited by 1,884
Michael, M. D., Kulkarni, R. N., Postic, C., Previs, S. F., Shulman, G. I., Magnuson, M. A., & Kahn, C. R. (2000) · Molecular Cell · doi:10.1016/s1097-2765(05)00015-8 · Cited by 1,296
Lipotoxic heart disease in obese rats: Implications for human obesity
Zhou, Y.-T., Grayburn, P., Karim, A., Shimabukuro, M., Higa, M., Baetens, D., Orci, L., & Unger, R. H. (2000) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.97.4.1784 · Cited by 1,265
Muscle‐derived interleukin‐6: mechanisms for activation and possible biological roles
FEBBRAIO, M. A., & PEDERSEN, B. K. (2002) · The FASEB Journal · doi:10.1096/fj.01-0876rev · Cited by 875
Shimomura, I., Matsuda, M., Hammer, R. E., Bashmakov, Y. K., Brown, M. S., & Goldstein, J. L. (2000) · Molecular Cell · doi:10.1016/s1097-2765(05)00010-9 · Cited by 860
Blüher, M., Michael, M. D., Peroni, O. D., Ueki, K., Carter, N., Kahn, B. B., & Kahn, C. R. (2002) · Developmental Cell · doi:10.1016/s1534-5807(02)00199-5 · Cited by 806
Prevention of fat-induced insulin resistance by salicylate
Kim, J. K., Kim, Y.-J., Fillmore, J. J., Chen, Y., Moore, I., Lee, J., Yuan, M., Li, Z. W., Karin, M., Perret, P., et al. (2001) · Journal of Clinical Investigation · doi:10.1172/jci11559 · Cited by 737
Potential Role of TNF-α in the Pathogenesis of Insulin Resistance and Type 2 Diabetes
Moller, D. E. (2000) · Trends in Endocrinology and Metabolism · doi:10.1016/s1043-2760(00)00272-1 · Cited by 730
New Perspectives into the Molecular Pathogenesis and Treatment of Type 2 Diabetes
Saltiel, A. R. (2001) · Cell · doi:10.1016/s0092-8674(01)00239-2 · Cited by 688
Cited by
Sorted by citations
Inducible nitric oxide synthase: Regulation, structure, and inhibition
Cinelli, M. A., Do, H. T., Miley, G. P., & Silverman, R. B. (2019) · Medicinal Research Reviews · doi:10.1002/med.21599 · Cited by 959
“Similarly, 5 improved insulin sensitivity and fasting hyperglycemia in obese and diabetic mice, which have iNOS overexpressed in the liver, muscle, and adipose tissue.(211) Obesity can also impair lymphatic function (possibly via the accumulation of perilymphatic inflammatory cells that produce iNOS), and treatment of…”
BackgroundRegulatory role for the arginine–nitric oxide pathway in metabolism of energy substrates
Jobgen, W. S., Fried, S. K., Fu, W. J., Meininger, C. J., & Wu, G. (2006) · The Journal of Nutritional Biochemistry · doi:10.1016/j.jnutbio.2005.12.001 · Cited by 729
“In genetically obese and diabetic rodent models, such as ob/ob mice and ZDF rats, iNOS protein expression in both adipose tissue and skeletal muscle was higher in comparison with the lean nonobese wild-types [118,119].”
BackgroundPositive and Negative Regulation of Insulin Signaling by Reactive Oxygen and Nitrogen Species
Bashan, N., Kovsan, J., Kachko, I., Ovadia, H., & Rudich, A. (2009) · Physiological Reviews · doi:10.1152/physrev.00014.2008 · Cited by 542
“iNOS was also proposed to play a role in hepatic insulin resistance in ob/ob mice (120).”
BackgroundDavis, B. J., Xie, Z., Viollet, B., & Zou, M. (2006) · Diabetes · doi:10.2337/diabetes.55.02.06.db05-1064 · Cited by 465
“In particular, elevated levels of NO caused by upregulation of high-output inducible NOS-II have been reported to occur in diabetes (41,42).”
BackgroundThe Physiology of Obese-Hyperglycemic Mice [ob/obMice]
Lindström, P. (2007) · The Scientific World JOURNAL · doi:10.1100/tsw.2007.117 · Cited by 372
Endothelial Dysfunction: Is There a Hyperglycemia-Induced Imbalance of NOX and NOS?
Meza, C. A., La Favor, J. D., Kim, D.-H., & Hickner, R. C. (2019) · International Journal of Molecular Sciences · doi:10.3390/ijms20153775 · Cited by 323
Molecular and cellular mechanisms linking inflammation to insulin resistance and β-cell dysfunction
Khodabandehloo, H., Gorgani‐Firuzjaee, S., Panahi, G., & Meshkani, R. (2015) · Translational research · doi:10.1016/j.trsl.2015.08.011 · Cited by 307
“iNOS inhibitor also increased the protein expression of IRS-1 and IRS-2, and enhanced IRS-1 and IRS-2-mediated insulin signaling in the liver of ob/ob mice [198].”
BackgroundRegulation of obesity and insulin resistance by nitric oxide
Sansbury, B. E., & Hill, B. G. (2014) · Free Radical Biology and Medicine · doi:10.1016/j.freeradbiomed.2014.05.016 · Cited by 274
“The NOS2 enzyme increases in abundance in pancreatic β cells [146], aorta [147], skeletal muscle [148], liver [149,150], and adipose tissue [151–153] of obese rodents.”
BackgroundObesity-induced Insulin Resistance and Hyperglycemia
Martyn, J. A. J., Kaneki, M., Yasuhara, S., Warner, D. S., & Warner, M. A. A. (2008) · Anesthesiology · doi:10.1097/aln.0b013e3181799d45 · Cited by 278
“It is also interesting to note that the expression of sterol regulatory element– binding protein, which is usually increased in hepatic insulin resistance, also was reduced after treatment with L-NIL.63 In addition, inhibition of iNOS by gene disruption also reversed the decreased IRS-1 expression and thereby improved…”
BackgroundMethodInfluentialHigh-Fat Diet Induces Hepatic Insulin Resistance and Impairment of Synaptic Plasticity
Liu, Z., Patil, I., Jiang, T., Sancheti, H., Walsh, J. P., Stiles, B. L., Yin, F., & Cadenas, E. (2015) · PLoS ONE · doi:10.1371/journal.pone.0128274 · Cited by 250
iNOS as a metabolic enzyme under stress conditions
Anavi, S., & Tirosh, O. (2019) · Free Radical Biology and Medicine · doi:10.1016/j.freeradbiomed.2019.10.411 · Cited by 229
The allenic carotenoid fucoxanthin, a novel marine nutraceutical from brown seaweeds
Miyashita, K., Nishikawa, S., Beppu, F., Tsukui, T., Abe, M., & Hosokawa, M. (2011) · Journal of the Science of Food and Agriculture · doi:10.1002/jsfa.4353 · Cited by 230
Emerging Role of Nitric Oxide and Heat Shock Proteins in Insulin Resistance
Molina, M. N., Ferder, L., & Manucha, W. A. (2015) · Current Hypertension Reports · doi:10.1007/s11906-015-0615-4 · Cited by 203
Hosokawa, M., Miyashita, T., Nishikawa, S., Emi, S., Tsukui, T., Beppu, F., Okada, T., & Miyashita, K. (2010) · Archives of Biochemistry and Biophysics · doi:10.1016/j.abb.2010.05.031 · Cited by 188
Šoškić, S., Dobutović, B. D., Sudar-Milovanovic, E. M., Obradovic, M. M., Nikolić, D., Djordjevic, J. D., Radak, D. J., Mikhailidis, D. P., & Isenović, E. R. (2011) · The Open Cardiovascular Medicine Journal · doi:10.2174/1874192401105010153 · Cited by 158
“Chronic low-grade inflammation has been proposed to be involved in the pathogenesis in obesity-related IR and T2DM [10].”
BackgroundInfluentialMi, Y., Qi, G., Fan, R., Qiao, Q., Sun, Y., Gao, Y.-Q., & Liu, X. (2017) · The FASEB Journal · doi:10.1096/fj.201700400rr · Cited by 145
“Chronic inflammation is intimately associated with obesity-induced insulin resistance (36).”
BackgroundNitric oxide, a janus-faced therapeutic target for diabetic microangiopathy—Friend or foe?
Yamagishi, S., & Matsui, T. (2011) · Pharmacological Research · doi:10.1016/j.phrs.2011.05.009 · Cited by 143
Nitrosative Stress and Pathogenesis of Insulin Resistance
Kaneki, M., Shimizu, N., Yamada, D., & Chang, K. (2007) · Antioxidants and Redox Signaling · doi:10.1089/ars.2006.1464 · Cited by 136
“a mediator of inflammation. iNOS was originally identified in activated macrophages (115) but is actually expressed in various tissues, including skeletal muscle, liver, and adipose tissue, even under a normal, unstressed condition (34, 103).”
Hyperglycaemia Enhances Nitric Oxide Production in Diabetes: A Study from South Indian Patients
Adela, R., Nethi, S. K., Bagul, P. K., Barui, A. K., Mattapally, S., Kuncha, M., Patra, C. R., Reddy, P. N. C., & Banerjee, S. (2015) · PLoS ONE · doi:10.1371/journal.pone.0125270 · Cited by 122
Nakazawa, H., Chang, K., Shinozaki, S., Yasukawa, T., Ishimaru, K., Yasuhara, S., Yu, Y., Martyn, J. A. J., Tompkins, R. G., Shimokado, K., et al. (2017) · PLoS ONE · doi:10.1371/journal.pone.0170391 · Cited by 118
Inducible Nitric Oxide Synthase Induction Underlies Lipid-Induced Hepatic Insulin Resistance in Mice
Charbonneau, A., & Marette, A. (2010) · Diabetes · doi:10.2337/db09-1238 · Cited by 116
“Further studies confirmed that iNOS is a potential target for alleviating the adverse effects of obesity on insulin’s glucoregulatory actions and vascular insulin resistance (3,4).”
BackgroundArçari, D. P., Bartchewsky, W., dos Santos, T. W., Oliveira, K. A., DeOliveira, C. C., Gotardo, É. M. F., Pedrazzoli, J., Gambero, A., Ferraz, L. F. C., Carvalho, P. D. O., et al. (2011) · Molecular and Cellular Endocrinology · doi:10.1016/j.mce.2011.01.003 · Cited by 116
Parveen, K., Khan, M. R., Mujeeb, M., & Siddiqui, W. A. (2010) · Chemico-Biological Interactions · doi:10.1016/j.cbi.2010.04.023 · Cited by 108
Collino, M., Aragno, M., Castiglia, S., Miglio, G., Tomasinelli, C. E., Boccuzzi, G., Thiemermann, C., & Fantozzi, R. (2010) · British Journal of Pharmacology · doi:10.1111/j.1476-5381.2010.00671.x · Cited by 107
“…further confirmed by pioglitazone’s ability to attenuate the diet-induced expression of the inflammatory enzymes COX-2 and iNOS, whose role in the development of insulin resistance has been recently documented in obese rats and in cultured hepatocytes (Fujimoto et al., 2005; Hsieh et al., 2009).”
BackgroundRetractedStadler, K. (2012) · Advances in experimental medicine and biology · doi:10.1007/978-1-4614-5441-0_21 · Cited by 106
Apoptosis in HepG2 cells exposed to high glucose
Chandrasekaran, K., Swaminathan, K., Chatterjee, S., & Dey, A. (2009) · Toxicology in Vitro · doi:10.1016/j.tiv.2009.10.020 · Cited by 99
A Novel Pathway of Insulin Sensitivity in Chromogranin A Null Mice
Gayen, J. R., Saberi, M., Schenk, S., Biswas, N., Vaingankar, S. M., Cheung, W. W., Najjar, S. M., O’Connor, D. T., Bandyopadhyay, G. K., & Mahata, S. K. (2009) · Journal of Biological Chemistry · doi:10.1074/jbc.m109.020636 · Cited by 98
Aging-Associated Dysfunction of Akt/Protein Kinase B: S-Nitrosylation and Acetaminophen Intervention
Wu, M., Katta, A., Gadde, M. K., Liu, H., Kakarla, S. K., Fannin, J. C., Paturi, S., Arvapalli, R. K., Rice, K. M., Wang, Y., et al. (2009) · PLoS ONE · doi:10.1371/journal.pone.0006430 · Cited by 97
“These increases occurred concomitant to increases in the amount of iNOS, an enzyme that catalyzes the production of nitric oxide needed for the S-nitrosylation reaction [18,19].”
BackgroundTanaka, J., Qiang, L., Banks, A. S., Welch, C. L., Matsumoto, M., Kitamura, T., Ido-Kitamura, Y., DePinho, R. A., & Accili, D. (2009) · Diabetes · doi:10.2337/db09-0167 · Cited by 97
“The present data dovetail with scattered evidence in the literature for a role of iNOS in the adverse metabolic consequences of hyperglycemia in skeletal muscle, adipose, and liver (36,37).”
ResultDrug Repositioning for Diabetes Based on 'Omics' Data Mining
Zhang, M., Luo, H., Xi, Z., & Rogaeva, E. A. (2015) · PLoS ONE · doi:10.1371/journal.pone.0126082 · Cited by 96
“Specifically, the gain of function (GOF) and the loss of function (LOF) roles in human or animal models were gathered to select antidiabetes protein targets [15–24].”
BackgroundLee, Y. A., Cho, E. J., & Yokozawa, T. (2008) · Journal of Agricultural and Food Chemistry · doi:10.1021/jf800639m · Cited by 93
Zanetti, M., Cappellari, G. G., Burekovic, I., Barazzoni, R., Stebel, M., & Guarnieri, G. (2010) · Experimental Gerontology · doi:10.1016/j.exger.2010.07.002 · Cited by 93
“In contrast iNOS has been strongly linked with insulin resistance and inhibition of iNOS reduces insulin levels (39) and restores the response to insulin vascular effects in diabetic animals (40).”
BackgroundMeijerink, J., Plastina, P., Vincken, J., Poland, M., Attya, M., Balvers, M. G. J., Gruppen, H., Gabriele, B., & Witkamp, R. F. (2011) · British Journal Of Nutrition · doi:10.1017/s0007114510005635 · Cited by 92
Jaja-Chimedza, A., Zhang, L., Wolff, K., Graf, B. L., Kuhn, P. E., Moskal, K., Carmouche, R. P., Newman, S. S., Salbaum, J. M., & Raskin, I. (2018) · Journal of Functional Foods · doi:10.1016/j.jff.2018.05.056 · Cited by 83
“In this study, MSE significantly regulated the gene expression of iNOS and NQO1 in vivo, which are associated with chronic inflammation, oxidative stress, and obesity-induced insulin resistance in mice (Fujimoto et al., 2005; Munday et al., 2010; Shinozaki et al., 2011), supporting the role of MIC-1 as the primary bio…”
BackgroundStadler, K., Bonini, M. G., Dallas, S., Jiang, J., Radí, R., Mason, R. P., & Kadiiska, M. B. (2008) · Free Radical Biology and Medicine · doi:10.1016/j.freeradbiomed.2008.06.023 · Cited by 81
“It is noteworthy that there is also abundant evidence indicating that iNOS mediates insulin resistance where inflammatory processes are involved [57,58].”
BackgroundMason, R. P., Jacob, R. F., Kubant, R., Ciszewski, A., Corbalan, J. J., & Maliñski, T. (2012) · Journal of Cardiovascular Pharmacology · doi:10.1097/fjc.0b013e31826be204 · Cited by 81
“The specific inducible NOS inhibitor, N6-(1-iminoethyl)-L-lysine (L-NIL), has been shown to reverse fasting hyperglycemia, improve insulin sensitivity, and ameliorate hyperinsulinemia in genetically obese diabetic (ob/ob) mice.(33) However, insulin-induced uptake of glucose into skeletal muscle was reversibly blocked…”
BackgroundTsuchiya, K., Sakai, H., Suzuki, N., Iwashima, F., Yoshimoto, T., Shichiri, M., & Hirata, Y. (2007) · Endocrinology · doi:10.1210/en.2006-1371 · Cited by 80
Modulation of Insulin Sensitivity by Insulin-Degrading Enzyme
González-Casimiro, C. M., Merino, B., Casanueva-Álvarez, E., Postigo, T., Cámara-Torres, P., Fernández-Díaz, C. M., Leissring, M. A., Cózar‐Castellano, I., & Perdomo, G. (2021) · Biomedicines · doi:10.3390/biomedicines9010086 · Cited by 81
Shinozaki, S., Choi, C. S., Shimizu, N., Yamada, M., Kim, M., Zhang, T., Shiota, G., Dong, H. H., Kim, Y.-B., & Kaneki, M. (2011) · Journal of Biological Chemistry · doi:10.1074/jbc.m110.187666 · Cited by 82
Park, S., Park, N.-Y., Valacchi, G., & Lim, Y. (2012) · Mediators of Inflammation · doi:10.1155/2012/984643 · Cited by 77
“iNOS inhibitors improved insulin sensitivity by increasing the protein expression of IRSs and enhancing IRSs-mediated insulin signaling in the liver of ob/ob mice [48].”
BackgroundResultRopelle, E. R., Pauli, J. R., Cintra, D. E., da Silva, A. S. R., de Souza, C. T., Guadagnini, D., Carvalho, B. M., Caricilli, A. M., Katashima, C. K., Filho, C., et al. (2012) · Diabetes · doi:10.2337/db12-0339 · Cited by 73
“Beyond the skeletal muscle, high levels of iNOS expression were also reported in the liver of ob/obmice, whereas L-NIL treatment was sufficient to enhance insulin-induced IRS-1- and IRS-2 phosphorylation (21).”
BackgroundIdentifying Molecular Targets of Lifestyle Modifications in Colon Cancer Prevention
Derry, M. M., Raina, K., Agarwal, C., & Agarwal, R. (2013) · Frontiers in Oncology · doi:10.3389/fonc.2013.00119 · Cited by 71
“With this in mind, the following is a comprehensive review identifying downstream target proteins of the above lifestyle risk factors, which are modulated during colon carcinogenesis and could be targeted for CRC prevention by novel agents including phytochemicals.”
BackgroundNitric oxide inhibits insulin-degrading enzyme activity and function through S-nitrosylation
Cordes, C. M., Bennett, R. G., Siford, G. L., & Hamel, F. G. (2008) · Biochemical Pharmacology · doi:10.1016/j.bcp.2008.12.006 · Cited by 71
“Enhanced expression of iNOS as a result of inflammation is a factor in insulin resistance, and depletion of iNOS has been shown to enhance insulin sensitivity [7,8,29].”
BackgroundBabacanoglu, C., Yildirim, N., Sadı, G., Pektaş, M. B., & Akar, F. (2013) · Food and Chemical Toxicology · doi:10.1016/j.fct.2013.07.026 · Cited by 69
Functional Relationship between Leptin and Nitric Oxide in Metabolism
Becerril, S., Rodrı́guez, A., Catalán, V., Ramírez, B., Unamuno, X., Portincasa, P., Gómez‐Ambrosi, J., & Frühbeck, G. (2019) · Nutrients · doi:10.3390/nu11092129 · Cited by 71
“iNOS is induced by inflammatory CK in skeletal muscle and fat, being involved in the pathogenesis of several metabolic disorders related with a low-grade chronic inflammatory state such as obesity-associated type 2 diabetes, characterized by insulin resistance [70,71].”
BackgroundCellular inflammatory responses: Novel insights for obesity and insulin resistance
Chen, H. (2006) · Pharmacological Research · doi:10.1016/j.phrs.2006.03.003 · Cited by 68
Dallaire, P., Bellmann, K., Laplante, M., Gélinas, S., Centeno-Baez, C., Penfornis, P., Peyot, M., Latour, M. G., Lamontagne, J., Trujillo, M. E., et al. (2008) · Diabetes · doi:10.2337/db08-0540 · Cited by 66
“More recently, iNOS disruption was also found to protect against the adverse effects of high-fat feeding on vascular insulin resistance (23) and to reduce insulin resistance in genetically obese ob/ob mice (24,25).”
BackgroundVerdugo‐Meza, A., Ye, J., Dadlani, H., Ghosh, S., & Gibson, D. L. (2020) · Nutrients · doi:10.3390/nu12051434 · Cited by 69
“Inhibitors of iNOS improve hepatic insulin resistance in genetically obese mice, demonstrating the detrimental role of iNOS on impairing insulin signaling [67].”
BackgroundSadı, G., Pektaş, M. B., Koca, H. B., Tosun, M., & Koca, T. (2015) · Gene · doi:10.1016/j.gene.2015.06.019 · Cited by 64
Inducible Nitric Oxide Distribution in the Fatty Liver of a Mouse with High Fat Diet-Induced Obesity
Ha, S.-K., & Chae, C. (2010) · EXPERIMENTAL ANIMALS · doi:10.1538/expanim.59.595 · Cited by 62
“The expression of iNOS is up-regulated by most inducers of obesity, hyperglycemia, and insulin resistance, including free fatty acids, endotoxins, and oxidative stress [12].”
BackgroundRegulation of carbohydrate metabolism by nitric oxide and hydrogen sulfide: Implications in diabetes
Gheibi, S., Samsonov, A. P., Gheibi, S., Vazquez, A. B., & Kashfi, K. (2020) · Biochemical Pharmacology · doi:10.1016/j.bcp.2020.113819 · Cited by 63
Functional Roles of Protein Nitration in Acute and Chronic Liver Diseases
Abdelmegeed, M. A., & Song, B. (2014) · Oxidative Medicine and Cellular Longevity · doi:10.1155/2014/149627 · Cited by 62
“AKT, IRβ, IRS-1, IRS-2 Decrease Decrease insulin signaling with increased hepatic insulin resistance and fatty liver [44]”
BackgroundCenteno-Baez, C., Dallaire, P., & Marette, A. (2011) · American Journal of Physiology-Endocrinology and Metabolism · doi:10.1152/ajpendo.00530.2010 · Cited by 60
Carvalho-Filho, M. A., Ropelle, E. R., Pauli, R. J., Cintra, D. E., Tsukumo, D. M. L., Silveira, L. R., Curi, R., Carvalheira, J. B. C., Velloso, L. A., & Saad, M. J. A. (2009) · Diabetologia · doi:10.1007/s00125-009-1498-1 · Cited by 63
“In more prolonged high-fat diet treatment these effects of iNOS on hepatic insulin resistance would probably be more evident [28].”
Ogresta, D., Mrzljak, A., Berković, M. C., Bilić-Čurčić, I., Stojsavljević, S., & Virović-Jukić, L. (2022) · Journal of Clinical and Translational Hepatology · doi:10.14218/jcth.2021.00268 · Cited by 58
Inhibition of adipocyte inflammation and macrophage chemotaxis by butein
Wang, Z., Lee, Y., Eun, J. S., & Bae, E. J. (2014) · European Journal of Pharmacology · doi:10.1016/j.ejphar.2014.05.031 · Cited by 59
Protective Effect of Proanthocyanidin against Diabetic Oxidative Stress
Yokozawa, T., Cho, E. J., Park, C. H., & Kim, J. H. (2011) · Evidence-based Complementary and Alternative Medicine · doi:10.1155/2012/623879 · Cited by 56
“COX-2 and iNOS expressions were up-regulated under insulin resistance, obesity, hyperglycemia, and oxidative stress [48].”
BackgroundZhang, J., Chen, Q., Zhong, J., Liu, C., Zheng, B., & Gong, Q. (2019) · Frontiers in Immunology · doi:10.3389/fimmu.2019.01050 · Cited by 57
Phenolics and anthocyanins in berries of European cranberry and their antimicrobial activity
Česonienė, L., Jasutienė, I., & Šarkinas, A. (2024) · PubMed · doi:10.5281/zenodo.11174808 · Cited by 56
Garcia, F. A. D. O., Rebouças, J. F., Balbino, T. Q., da Silva, T. G., de Carvalho-Júnior, C. H. R., Cerqueira, G. S., Brito, G. A. D. C., & Viana, G. S. D. B. (2015) · Journal of Inflammation · doi:10.1186/s12950-015-0080-5 · Cited by 57
“Earlier results [57] suggest that iNOS plays a role in hyperglycemia and contributes to hepatic insulin resistance in ob/ob mice.”
ResultSong, J., Li, T., Cheng, X., Ji, X., Gao, D., Du, ., Jiang, N., Liu, X., & Mao, X. (2016) · Food & Function · doi:10.1039/c5fo01622c · Cited by 53
Nitric oxide mediates the insulin sensitizing effects of β-sitosterol in high fat diet-fed rats
Radika, M. K., Viswanathan, P., & Anuradha, C. V. (2013) · Nitric Oxide · doi:10.1016/j.niox.2013.04.007 · Cited by 52
Güney, C., Bal, N. B., & Akar, F. (2023) · Heliyon · doi:10.1016/j.heliyon.2023.e18896 · Cited by 53
“Inflammatory factors, especially iNOS, may have a role in the coupling of metabolic and vascular insulin resistance as well as impaired insulin signaling in the liver from diabetic obese mice [182,183].”
BackgroundBecerril, S., Rodrı́guez, A., Catalán, V., Sáinź, N., Ramírez, B., Collantes, M., Peñuelas, I., Gómez‐Ambrosi, J., & Frühbeck, G. (2010) · PLoS ONE · doi:10.1371/journal.pone.0010962 · Cited by 50
“In this line, the present study shows that ablation of the iNOS gene in ob/ob mice improves the impaired carbohydrate metabolism, as previously described [69,70], decreasing glycemia and insulinemia as well as increasing adiponectinemia, at the same time as it ameliorates lipid homeostasis through a decrease in serum…”
ResultPasarín, M., Abraldeṣ, J. G., Liguori, E., Kok, B., & Mura, V. L. (2017) · World Journal of Gastroenterology · doi:10.3748/wjg.v23.i37.6777 · Cited by 52
Song, B., Akbar, M. D., Jo, I., Hardwick, J. P., & Abdelmegeed, M. A. (2015) · Advances in pharmacology · doi:10.1016/bs.apha.2015.04.002 · Cited by 51
Coudriet, G. M., Delmastro-Greenwood, M. M., Previte, D. M., Marré, M. L., O’Connor, E., Novak, E. M., Vincent, G., Mollen, K. P., Lee, S., Dong, H. H., et al. (2017) · Antioxidants · doi:10.3390/antiox6040085 · Cited by 50
“Previous studies have shown that NF-κB-dependent inducible nitric oxide synthase (iNOS) plays an important role in insulin resistance [58] and that liver-specific inhibition of iNOS reverses obesity-induced insulin resistance [59,60].”
Becerril, S., Rodríguez, A., Catalán, V., Méndez-Giménez, L., Ramírez, B., Sáinź, N., Llorente, M., Unamuno, X., Gómez‐Ambrosi, J., & Frühbeck, G. (2018) · International Journal of Obesity · doi:10.1038/s41366-018-0005-5 · Cited by 48
Induction of cytochrome promotes liver injury in ob/ob mice
Dey, A., & Cederbaum, A. I. (2007) · Hepatology · doi:10.1002/hep.21603 · Cited by 46
Müller, C., Gardemann, A., Keilhoff, G., Peter, D., Wiswedel, I., & Schild, L. (2012) · Phytomedicine · doi:10.1016/j.phymed.2011.12.002 · Cited by 46
Pinto, L. D. F., Compri, C. M., Fornari, J. V., Bartchewsky, W., Cintra, D. E., Trevisan, M. S., Carvalho, P. D. O., Ribeiro, M. L., Velloso, L. A., Saad, M. J. A., et al. (2010) · Liver International · doi:10.1111/j.1478-3231.2009.02200.x · Cited by 46
“In ob/ob mice, iNOS expression was increased in the liver and treatment with iNOS inhibitor reversed fasting hyperglycaemia and improved insulin sensitivity through enhanced IRS-mediated insulin signalling in the liver (28).”
BackgroundKim, D., Nepali, S., Son, J.-S., Poudel, B., Lee, J., & Lee, Y. (2015) · Pharmacognosy Magazine · doi:10.4103/0973-1296.160470 · Cited by 43
“It has been reported that iNOS is a key mediator of inflammation in obesity‐induced insulin resistance.[4,32] Figure 5: Luteolin inhibited protein expression of MCP-1 and interleukin (IL)-6”
BackgroundHigh-fructose corn syrup-induced hepatic dysfunction in rats: improving effect of resveratrol
Sadı, G., Ergin, V., Yılmaz, G., Pektaş, M. B., Yıldırım, O. G., Menevşe, A., & Akar, F. (2014) · European Journal of Nutrition · doi:10.1007/s00394-014-0765-1 · Cited by 43
Natali, A., Ribeiro, R. T., Baldi, S., Tulipani, A., Rossi, M., Venturi, E., Mari, A., Macedo, M. P., & Ferrannini, E. (2013) · Diabetologia · doi:10.1007/s00125-013-2836-x · Cited by 43
“Other studies showing a direct role of NO in inducing hepatic insulin resistance have used models in which excess NO was generated through liver-specific overexpression of the inducible nitric oxide synthase (NOS) isoform [11].”
BackgroundKanuri, B., Kanshana, J. S., Rebello, S. C., Pathak, P., Gupta, A. P., Gayen, J. R., Jagavelu, K., & Dikshit, M. (2017) · Scientific Reports · doi:10.1038/srep41009 · Cited by 40
Nitrosative modifications of protein and lipid signaling molecules by reactive nitrogen species
White, P. J., Charbonneau, A., Cooney, G. J., & Marette, A. (2010) · American Journal of Physiology-Endocrinology and Metabolism · doi:10.1152/ajpendo.00510.2010 · Cited by 49
“iNOS disruption was also found to partially prevent muscle insulin resistance in genetically obese ob/ob mice (117), whereas downregulation of iNOS by selective inhibitors or antisense oligonucleotides improved hepatic and muscle insulin action, respectively, in these animals (21, 40).”
BackgroundHa, S. K., Kim, J., & Chae, C. (2011) · Journal of Comparative Pathology · doi:10.1016/j.jcpa.2010.11.011 · Cited by 41
Nozaki, Y., Fujita, K., Wada, K., Yoneda, M., Kessoku, T., Shinohara, Y., Imajo, K., Ogawa, Y., Nakamuta, M., Saito, S., et al. (2015) · BMC Gastroenterology · doi:10.1186/s12876-015-0269-3 · Cited by 38
“Nitric oxide (NO) plays an important role in liver disease associated with IR and inflammation, and it has been reported that chronic and systemic deficiency of inducible nitric oxide synthase (iNOS) ameliorated high fat diet (HFD)-induced whole-body IR [5-7].”
BackgroundBrain-Defective Insulin Signaling Is Associated to Late Cognitive Impairment in Post-Septic Mice
Neves, F., Marques, P. T., Barros‐Aragão, F. G. Q., Nunes, J. B., Venancio, A. M., Cozachenco, D., Frozza, R. L., Passos, G. F., da Costa, R., de Oliveira, J., et al. (2016) · Molecular Neurobiology · doi:10.1007/s12035-016-0307-3 · Cited by 40
Hepatic Lysosomal iNOS Activity Impairs Autophagy in Obesity
Qian, Q., Zhang, Z., Li, M., Savage, K., Cheng, D., Rauckhorst, A. J., Ankrum, J. A., Taylor, E. B., Ding, W., Xiao, Y., et al. (2019) · Cellular and Molecular Gastroenterology and Hepatology · doi:10.1016/j.jcmgh.2019.03.005 · Cited by 38
The Inhibitory Effect of Tartary Buckwheat Extracts on Adipogenesis and Inflammatory Response
Lee, M.-S., Shin, Y., Jung, S., Kim, S.-Y., Jo, Y.-H., Kim, C., Yun, M., Lee, S.-J., Sohn, J., Yu, H.-J., et al. (2017) · Molecules · doi:10.3390/molecules22071160 · Cited by 37
“Moreover, rutin exerts protective effects on inflammatory diseases such as acute pancreatitis [54], diabetic cardiomyopathy [55], neuroinflammation [56] in vivo.”
BackgroundGarcia, F. A. D. O., Pinto, S. F., Cavalcante, A. F., Lucetti, L. T., Menezes, S. M. S., Felipe, C. F. B., Alves, A. P. N., Brito, G. A. D. C., Cerqueira, G. S., & Viana, G. S. (2014) · SpringerPlus · doi:10.1186/2193-1801-3-283 · Cited by 39
“Furthermore, inducible nitric oxide synthase (iNOS) was shown to play a role in fasting hyperglycemia, contributing to hepatic insulin resistance, in a model of obese diabetic mice (Fujimoto et al. 2005).”
BackgroundTsuzuki, T., Shinozaki, S., Nakamoto, H., Kaneki, M., Goto, S., Shimokado, K., Kobayashi, H., & Naıto, H. (2015) · PLoS ONE · doi:10.1371/journal.pone.0132029 · Cited by 35
“We and others have shown that inducible nitric oxide synthase (iNOS) inhibitor treatment improves insulin signaling at the level of insulin receptor substrate-1 (IRS-1) and -2 and Akt in the liver in genetically obese diabetic (ob/ob) mice [6, 7].”
BackgroundStanimirović, J., Obradovic, M. M., Jovanović, A., Sudar-Milovanovic, E. M., Zafirovic, S. S., Pitt, S. J., Stewart, A. J., & Isenović, E. R. (2016) · Nitric Oxide · doi:10.1016/j.niox.2016.02.007 · Cited by 35
Sugita, M., Sugita, H., & Kaneki, M. (2007) · Arteriosclerosis Thrombosis and Vascular Biology · doi:10.1161/atvbaha.107.140673 · Cited by 35
Anti-Inflammatory and Antioxidant Properties of a New Arylidene-Thiazolidinedione in Macrophages
Faine, L. A., Rudnicki, M., de César, F. A., Heras, B. D. L., Boscá, L., Souza, É. S., Hernandes, M. Z., Galdino, S. L., de Lima, M. D. C. A., Pitta, I. D. R., et al. (2011) · Current Medicinal Chemistry · doi:10.2174/092986711796504600 · Cited by 37
“Interestingly, accumulating evidence indicates a close link between iNOS and insulin resistance [35].”
BackgroundLiver Sinusoidal Endothelial Cells Link Hyperinsulinemia to Hepatic Insulin Resistance
Tsuchiya, K., & Accili, D. (2013) · Diabetes · doi:10.2337/db12-1296 · Cited by 34
Gumede, N. M., Lembede, B. W., Brooksbank, R. L., Erlwanger, K. H., & Chivandi, E. (2019) · Journal of Medicinal Food · doi:10.1089/jmf.2019.0120 · Cited by 33
Sugita, M., Sugita, H., Kim, M., Mao, J., Yasuda, Y., Habiro, M., Shinozaki, S., Yasuhara, S., Shimizu, N., Martyn, J. A. J., et al. (2011) · Metabolism · doi:10.1016/j.metabol.2011.06.001 · Cited by 35
Obesity disrupts the pituitary-hepatic UPR communication leading to NAFLD progression
Qian, Q., Li, M., Zhang, Z., Davis, S. W., Rahmouni, K., Norris, A. W., Cao, H., Ding, W., Hotamışlıgil, G. S., & Yang, L. (2024) · Cell Metabolism · doi:10.1016/j.cmet.2024.04.014 · Cited by 34
Redox Regulation of Insulin Degradation by Insulin-Degrading Enzyme
Cordes, C. M., Bennett, R. G., Siford, G. L., & Hamel, F. G. (2011) · PLoS ONE · doi:10.1371/journal.pone.0018138 · Cited by 34
“may result in locally increased iNOS expression and NO release [13,14,15,16,17].”
BackgroundBlocking iNOS and endoplasmic reticulum stress synergistically improves insulin resistance in mice
Zanotto, T. M., Quaresma, P. G. F., Guadagnini, D., Weissmann, L., Santos, A. C., Vecina, J. F., Calisto, K. L., Santos, A., Prada, P. O., & Saad, M. J. A. (2016) · Molecular Metabolism · doi:10.1016/j.molmet.2016.12.005 · Cited by 32
Subramanian, S., Pallati, P. K., Sharma, P., Agrawal, D. K., & Nandipati, K. C. (2017) · Journal of Translational Medicine · doi:10.1186/s12967-017-1187-7 · Cited by 32
“Increased overexpression of CCR7 [38] and iNOS [39] in the obese diabetic group in a higher number of patients in omentum tissues compared to obese non-diabetics, suggests that the predominance of M1 macrophage markers in ATMs regulates the amplitude of adipose tissue inflammation.”
BackgroundRetractedNitric oxide dysregulates adipocytokine expression in 3T3-L1 adipocytes
野崎, 真., Fukuhara, A., Segawa, K., Okuno, Y., Abe, M., Hosogai, N., Matsuda, M., Komuro, R., & Shimomura, I. (2007) · Biochemical and Biophysical Research Communications · doi:10.1016/j.bbrc.2007.09.084 · Cited by 31
Nakashima, M., Nakamura, K., Nishihara, T., Ichikawa, K., Nakayama, R., Takaya, Y., Toh, N., Akagi, S., Miyoshi, T., Akagi, T., et al. (2023) · Nutrients · doi:10.3390/nu15030748 · Cited by 35
“The oxidative stress and inflammation, that are also associated with NAFLD as above mentioned, also cause endothelial vascular dysfunction [41,42], and these changes can also cause CVD in patients with NAFLD [43].”
BackgroundChen, M., Zheng, H. X., Xu, M., Zhao, L., Zhang, Q., Song, J., Zhao, Z., Lu, S., Weng, Q., Wu, X., et al. (2019) · Bioscience Reports · doi:10.1042/bsr20181379 · Cited by 30
Obesity, insulin resistance, and skeletal muscle nitric oxide synthase
Kraus, R. M., Houmard, J. A., Kraus, W. E., Tanner, C. J., Pierce, J. R., Choi, M. D., & Hickner, R. C. (2012) · Journal of Applied Physiology · doi:10.1152/japplphysiol.01018.2011 · Cited by 28
“The present iNOS and insulin sensitivity results contradict previous reports that showed that insulin resistance was related to an elevation in skeletal muscle iNOS expression (11, 12, 21, 43, 53, 55, 58).”
BackgroundResultLima‐Cabello, E., Ramírez, J. D. D. A., Morales, S., Clemente, A., & Jiménez-López, J. C. (2019) · Antioxidants · doi:10.3390/antiox9010012 · Cited by 30
“, IR [38], promoting islet β-cell apoptosis [39] and the progression of diseases concomitant with inflammation [40].”
BackgroundZhao, Z., Eckert, R. L., & Reece, E. A. (2012) · Reproductive Sciences · doi:10.1177/1933719111434543 · Cited by 27
Zhang, Y., Dong, H., Wang, M., & Zhang, J. (2016) · Journal of Diabetes Research · doi:10.1155/2016/8492780 · Cited by 27
“It has been reported that diabetic mice had significantly increased levels of iNOS expression and activity in the serum [37, 38].”
Background
Metadata
- Authors
- Fujimoto, M., Shimizu, N., Kunii, K., Martyn, J. A. J., Ueki, K., & Kaneki, M.
- Affiliations
- Harvard University (US)
- The University of Tokyo (JP)
- Venue
- Diabetes
- Publisher
- American Diabetes Association
- Published
- 2005-05-01
- Volume
- 54
- Issue
- 5
- Pages
- 1340-1348
- ISSN
- 0012-1797 (ISSN-L)
- 1939-327X
- OpenAlex
- W2138266804
- Cited by
- 209
- References
- 47
- Citations by year
- 2026: 3 · 2025: 3 · 2024: 6 · 2023: 5 · 2022: 6 · 2021: 11 · 2020: 9 · 2019: 15 · 2018: 12 · 2017: 10 · 2016: 10 · 2015: 24 · 2014: 14 · 2013: 7 · 2012: 15
- FWCI
- 4.32
- Type
- journal article
- Language
- en
- Open access
- bronze
- doi.org
- Locations
- Diabetes (publishedVersion)
- PubMed (publishedVersion)
- Funders
- Shriners Hospitals for Children
- National Institutes of Health
- National Institute of General Medical Sciences (R01GM055082, R01GM031569, R01GM061411)
- National Institute of Diabetes and Digestive and Kidney Diseases (R01DK058127)
- Topics
- Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Adipokines, Inflammation, and Metabolic Diseases
- Health Sciences › Medicine › Physiology (medical) › Nitric Oxide and Endothelin Effects
- Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Pancreatic function and diabetes
- Keywords
- inducible nitric oxide synthase, fasting hyperglycemia, hepatic insulin resistance, insulin signaling, IRS-1, insulin receptor substrate 2, L-NIL, ob/ob mice, obesity, type 2 diabetes, nitric oxide, chronic inflammation, hepatocytes
- MeSH terms
- Animals, Cells, Cultured, Diabetes Mellitus, Type 2, Enzyme Inhibitors, Fasting, Hyperglycemia, Insulin, Insulin Resistance, Liver, Lysine, Male, Mice, Obese, Signal Transduction, Nitric Oxide Synthase, Phosphatidylinositol 3-Kinases, Nitric Oxide Donors, Hepatocytes, Mice, Nitric Oxide Synthase Type II
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review